Can L-Theanine Help Treat Symptoms of Bipolar Disorder?

Healthline
12 September 2022
https://www.healthline.com/health/bipolar-disorder/l-theanine

L-theanine is an amino acid found in tea. It is a relaxing agent that is known to relieve stress and anxiety. These effects can also be felt in people with psychological disorders, including bipolar disorder. Some people even claim to experience improved concentration.

Mesenteric Panniculitis, Sclerosing Mesenteritis and Mesenteric Lipodystrophy: Descriptive Review of a Rare Condition

Clin Colon Rectal Surg
10 August 2022
https://pubmed.ncbi.nlm.nih.gov/35966977/

Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial

Braz J Anesthesiol
18 August 2022
https://pubmed.ncbi.nlm.nih.gov/35988815/

 

Asher Goldstein, MD - His experience with LDN as a Pain Specialist; LDN Radio Show 2022. (LDN; low dose naltrexone)

 

 

Linda: Welcome to the LDN radio show brought to you by the LDN Research Trust. I'm your host Linda Elsegood.  I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.

 

The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details

 

Low Dose Naltrexone (LDN) Provides Surprising Pain Relief

The People's Pharmacy
18 August 2022
https://www.peoplespharmacy.com/articles/low-dose-naltrexone-ldn-provides-surprising-pain-relief

 

Linda Elsegood: Welcome to the LDN radio show brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.

Low-dose naltrexone (LDN) hope for patients with longCOVID syndrome?

MedExpress.pl
07 August 2022
https://www.medexpress.pl/niskodawkowy-naltrexon-ldn-nadzieja-dla-chorych-z-zespolem-longcovid/85098